Willis Johnson & Associates Inc. Raises Stock Holdings in AbbVie Inc. (NYSE:ABBV)

Willis Johnson & Associates Inc. increased its position in AbbVie Inc. (NYSE:ABBV – Get Rating) by 13.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,336 shares of the company’s stock after acquiring an additional 281 shares during the period. Willis Johnson […]

Related Keywords

Societe Generale ,Roberta Michael ,Carriec Strom ,Piper Sandler ,Morgan Stanley ,Thrivent Financial For Lutherans ,Camden National Bank ,Exchange Commission ,Eastover Investment Advisors ,Wells Fargo Company ,Willis Johnson Associates Inc ,Abbvie Inc ,Mission Capital ,Willis Johnson ,Get Rating ,National Bank ,Investment Advisors ,Vice Chairman Robert ,Vie Profile ,Vie Inc ,Visit Holdingschannel ,Abbvie ,Nyse Abbv ,Abbv ,Medical ,00287y10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,